Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAGBiotechnology
+$2.32 today
- Market cap
- $1.83B
- Beta
- 0.00
Volume 0.30M
Average 0.34M
COAG Total Non-current Liabilities
All obligations due after more than one year.
Hemab Therapeutics Holdings, Inc. Common StockNASDAQ: COAG
Total Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total non-current liabilities of $566K in Q2 FY2026
Q2 FY2026 total non-current liabilities was $566K.
Context
- Total non-current liabilities amounted to 0.1% of total assets at the end of Q2 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 360.74M USD
- Year-over-year change
- —
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 360.74M | — |
Total Non-current Liabilities vs competitors
How COAG compares with its peers on the latest reported figures
- COAG's Jun 2026 total non-current liabilities of $566K is the 4th highest of the 5 companies compared; the peer median is $31.12M.
- Total non-current liabilities amounts to 0.1% of total assets for COAG, versus a peer median of 4.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $570.17M | +6.5% | +54.4% | 73.2% | |
IRONDisc Medicine, Inc. | Sep 2026 | $60.88M | +100.8% | +209.4% | 8.7% |
DMRADamora Therapeutics, Inc. | Mar 2026 | $1.37M | -6.6% | -37.3% | 0.3% |
COAGHemab Therapeutics Holdings, Inc. Common Stock | Jun 2026 | $566K | — | — | 0.1% |
| Mar 2026 | $55K | — | -39.7% | 0.1% | |
| Peer median (excluding COAG) | $31.12M | +6.5% | +8.6% | 4.5% | |
Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
Intrinsic Alpha fair value
Locked
Current Price
$39.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.